Barricaid logo

Barricaid Funding & Investors

Adjacent to a lumbar discectomy, the Barricaid® device is designed to close large defects (|5mm) in the annulus, which often lead to disc reherniation and/or disc collapse. Barricaid is a permanent implant with two components - an occlusion component and an anchor.

barricaid.com

Total Amount Raised: $186,333,584

Barricaid Funding Rounds

  • Series E

    $52,000,000

    Series E Investors

    Questa Capital Management
    New Enterprise Associates (NEA)
    Greenspring Associates
    Quadrille Capital
    Delos Capital Management
  • Debt Financing

    $28,000,000

    Debt Financing Investors

    Centre for Genomic Regulation (CRG)
    Delos Capital Management
    New Enterprise Associates (NEA)
    Quadrille Capital
  • Series Unknown

    $17,877,087

    Series Unknown Investors

    CRG
  • Series Unknown

    $17,256,239

    Series Unknown Investors

    Greenspring Associates
  • Series Unknown

    $18,000,251

    Series Unknown Investors

    New Enterprise Associates (NEA)
    Spray Venture Partners
    New Leaf Venture Partners
  • Series D

    $21,000,000

    Series D Investors

    New Enterprise Associates (NEA)
    Spray Venture Partners
    Sprout Group
  • Series C

    $25,000,000

    Series C Investors

    Spray Venture Partners
    New Enterprise Associates (NEA)
    Sprout Group
  • Series B

    $7,200,000

    Series B Investors

    New Enterprise Associates (NEA)
    Spray Venture Partners
Funding info provided by Diffbot.